SIMCERE PHARMACEUTICAL GROUP Deferred Tax Assets, Valuation Allowance

SIMCERE PHARMACEUTICAL GROUP Deferred Tax Assets, Valuation Allowance

SIMCERE PHARMACEUTICAL GROUP had Deferred Tax Assets, Valuation Allowance of CNY 7.75 million as of 2012-12-31, per its 20-F filed 2013-04-26.

Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance

us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2013-04-26

• 2012-12-31: Deferred Tax Assets, Valuation Allowance 7.75M CNY.
• 2011-12-31: Deferred Tax Assets, Valuation Allowance 2.34M CNY.